Solera Health, Inc.

Solera Health, Inc. is a US-based company specializing in digital health management solutions aimed at improving healthcare efficiency, reducing costs, and enhancing health outcomes for organizations and their members. Founded in 2015 by Brenda Schmidt, Solera Health, Inc. is headquartered in Phoenix, US.

The company focuses on connecting individuals to personalized health programs through a value-based digital platform. It has completed a total of 7 deals, with its most recent funding round being Series E, in which it raised USD 40. 00 mn on January 14, 2025, with participation from investors including Adams Street Partners and Health Care Service Corporation. The total amount raised by the company stands at USD 40.

00 mn, with a current company valuation of USD 144. 60 mn. Solera Health specializes in digital health management solutions designed to enhance healthcare operations, reduce costs, and improve health outcomes for organizations and their members. The company's core offerings include a value-based digital platform that connects individuals to personalized health programs tailored to specific needs.

Through proprietary clinical algorithms, Solera effectively matches users with various health solutions across domains such as digestive health, hypertension, mental health, musculoskeletal issues, tobacco cessation, women's health, weight management, and diabetes management. The company serves a diverse clientele, including employers, health plans, and individual consumers, focusing on markets primarily in the United States. Solera Health operates under a pay-for-performance pricing model, aligning its financial incentives with the health outcomes of its participants. This structure means that both Solera and its network partners benefit financially only when participants achieve improved health results.

The company's revenue is generated through partnerships and direct contracts with employers and health plans, which may include subscription fees for access to its digital health solutions, such as the Solera HALO™ platform and other specific programs like the Dario diabetes management solution. Pricing structures may vary based on the services selected and the needs of the client. As a result, revenue is contingent upon the engagement and effectiveness of the health solutions provided to clients and end users. In January 2025, Solera Health, Inc.

raised USD 40. 00 mn in Series E funding to support the expansion of its HALO™ platform. The company plans to develop and launch new products while expanding its market presence. Specific geographic regions targeted for expansion include additional states across the US, aiming to enhance service delivery and reach by 2026.